Benlysta (belimumab) - GSK
Imaavy (nipocalimab-aahu) - J&J
Rituxan (rituximab) - Roche
dazodalibep (HZN-4920) - Amgen
iscalimab (CFZ533) - Novartis
Orencia (abatacept) - BMS
ianalumab (VAY736) - Novartis
http://www.ncbi.nlm.nih.gov/pubmed/42732083
 
Veli Yazisiz
 
Sep 14, 2026
 
Prev Next